We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+6.31%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$3.92B
AUM Growth
-$967M
Cap. Flow
-$852M
Cap. Flow %
-21.77%
Top 10 Hldgs %
42.44%
Holding
108
New
15
Increased
23
Reduced
16
Closed
19

Top Buys

Rank Stock Value
1
MANE
Veradermics Inc
MANE
+$210M
2
CAPR icon
Capricor Therapeutics
CAPR
+$54.2M
3
VMC icon
Vulcan Materials
VMC
+$53.4M
4
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$46.6M
5
PFGC icon
Performance Food Group
PFGC
+$35.4M

Top Sells

Rank Stock Value
1
ERAS icon
Erasca
ERAS
+$131M
2
KO icon
Coca-Cola
KO
+$96.7M
3
MSFT icon
Microsoft
MSFT
+$64.7M
4
NOW icon
ServiceNow
NOW
+$59.7M
5
CRM icon
Salesforce
CRM
+$53M

Sector Composition

Rank Sector Weight
1 Healthcare 65.36%
2 Technology 6.7%
3 Consumer Discretionary 5.89%
4 Financials 4.13%
5 Consumer Staples 3.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LXEO icon
51
Lexeo Therapeutics
LXEO
$368M
$7.17M 0.18%
1,250,000
– –
COHR icon
52
Coherent
COHR
$54.3B
$7.15M 0.18%
30,000
-107,930
-78% -$24.7M
IFRX icon
53
InflaRx
IFRX
$272M
$7.1M 0.18%
7,933,910
– –
DHR icon
54
Danaher
DHR
$144B
$6.9M 0.18%
36,380
-207,920
-85% -$44.3M
ABT icon
55
Abbott
ABT
$175B
$6.87M 0.18%
66,920
+15,900
+31% +$1.8M
TMO icon
56
Thermo Fisher Scientific
TMO
$198B
$6.59M 0.17%
13,400
– –
MDT icon
57
Medtronic
MDT
$106B
$6.26M 0.16%
72,260
+47,200
+188% +$4.52M
JNJ icon
58
Johnson & Johnson
JNJ
$609B
$5.72M 0.15%
23,400
-75,386
-76% -$17.6M
KZR
59
DELISTED
Kezar Life Sciences
KZR
$5.32M 0.14%
716,759
– –
ISRG icon
60
Intuitive Surgical
ISRG
$122B
$5.21M 0.13%
11,300
+6,100
+117% +$3.09M
AVR
61
Anteris Technologies
AVR
$823M
$4.72M 0.12%
+850,000
New +$4.88M
COR icon
62
Cencora
COR
$59.9B
$3.92M 0.1%
12,488
– –
MSLE
63
Satellos Bioscience
MSLE
$186M
$2.67M 0.07%
+475,000
New +$4.67M
MTD icon
64
Mettler-Toledo International
MTD
$26.5B
$2.48M 0.06%
1,964
– –
NTRA icon
65
Natera
NTRA
$38.9B
$2.02M 0.05%
10,100
– –
DXCM icon
66
DexCom
DXCM
$29.6B
$1.99M 0.05%
31,680
– –
SYK icon
67
Stryker
SYK
$123B
$1.93M 0.05%
5,860
– –
TSLA icon
68
Tesla
TSLA
$1.43T
$1.92M 0.05%
5,177
-86,075
-94% -$35.5M
TLN
69
Talen Energy Corp
TLN
$17.8B
$1.91M 0.05%
+5,970
New +$2.11M
MDLN
70
Medline Inc
MDLN
$33.6B
$1.89M 0.05%
42,500
– –
MSFT icon
71
Microsoft
MSFT
$2.93T
$1.84M 0.05%
4,970
-154,725
-97% -$64.7M
MCK icon
72
McKesson
MCK
$98.5B
$1.58M 0.04%
1,830
– –
HCA icon
73
HCA Healthcare
HCA
$82.3B
$1.51M 0.04%
3,190
– –
EW icon
74
Edwards Lifesciences
EW
$49.4B
$1.5M 0.04%
18,700
+7,600
+68% +$627K
IQV icon
75
IQVIA
IQV
$34.4B
$1.22M 0.03%
7,175
– –
1 2
3
4 5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
AA
Alesco Advisors Pittsford, New York $3.92B AUM 15.21% 1-Year Est. Return
DACG
Donor Advised Charitable Giving San Francisco, California $3.92B AUM 59.92% 1-Year Est. Return
CCM
Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Suvretta Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Suvretta Capital Management held 108 positions worth $3.92B, down 20% from $4.88B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Suvretta Capital Management withdrew a net $852M in Q1 2026, closing 19 positions and reducing 16 holdings. Its most notable exit was Coca-Cola, an estimated $96.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 65% of assets, up from 51% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Suvretta Capital Management opened a new position in Veradermics Inc worth $263M.

  • Suvretta Capital Management's largest Q1 2026 buy was Veradermics Inc: 4,168,970 shares worth $263M.
  • Suvretta Capital Management added most to Capricor Therapeutics in Q1 2026, an estimated $54.2M increase.
  • Suvretta Capital Management's biggest Q1 2026 reduction was Erasca, cutting an estimated $131M.
  • Suvretta Capital Management fully exited Coca-Cola in Q1 2026, selling an estimated $96.7M.
  • Suvretta Capital Management's ten largest holdings make up 42% of its $3.92B portfolio in Q1 2026.
  • Suvretta Capital Management opened 15 new positions and closed 19 in Q1 2026.
  • Suvretta Capital Management's portfolio value fell 20% quarter-over-quarter to $3.92B.

Based on Suvretta Capital Management's 13F filing for Q1 2026, filed 15 May 2026.